Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
---|
06/10/2004 | US20040110208 Use of exonuclease for removal of nucleotides from nucleic acids which then pass from a reaction chamber through a microfluidic channel and enter a nanochannel packed with nanoparticle aggregates |
06/10/2004 | CA2505266A1 2'-0-trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same |
06/09/2004 | EP1425022A1 Mutagenic nucleoside analogs for the treatment of viral disease |
06/09/2004 | CN1503805A Salts of avermectins substituted in the 4''-position and having pesticidal properties |
06/09/2004 | CN1502622A Diuridine tetraphosphate or salt crystal thereof, process for producing the same, and process for producing the compounds |
06/09/2004 | CN1152881C New indolocarbazole alkaloids from marine actinomycete, its composition and use |
06/08/2004 | US6747143 Methods for polymer synthesis |
06/08/2004 | US6747142 Multiple methoxyoxalamido and succinimido precursors for nucleophilic addition |
06/03/2004 | WO2004046368A1 Novel antibiotic muraminomicin |
06/03/2004 | WO2004046331A2 2’-branched nucleosides and flaviviridae mutation |
06/03/2004 | WO2004046159A1 Antiviral nucleoside derivatives |
06/03/2004 | WO2004046147A1 Polynucleotide derivative and use thereof |
06/03/2004 | WO2004046066A1 Method for deuteration or tritiation of heterocyclic ring |
06/03/2004 | WO2004045545A2 Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression |
06/03/2004 | WO2004045371A2 Methods for diagnosing the presence or stage of cancer |
06/03/2004 | WO2003020739A3 Novel lna compositions and uses thereof |
06/03/2004 | US20040106785 Inhibitors of RNA dependent RNA polymerase and uses thereof |
06/03/2004 | CA2506129A1 2'-branched nucleosides and flaviviridae mutation |
06/03/2004 | CA2506010A1 A method for deuteration of a heterocyclic ring |
06/03/2004 | CA2505735A1 Methods for diagnosing the presence or stage of cancer |
06/02/2004 | EP1424341A2 Production method for purine nucleotide derivative disodium crystals and alcohol removing method |
06/02/2004 | CN1501941A Chemical compounds |
06/02/2004 | CN1501940A Composition and method for inhibiting platelet aggregation |
06/02/2004 | CN1501939A Crystal of pyrimidine nucleoside derivative |
06/02/2004 | CN1500800A Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (HBV) |
06/02/2004 | CN1152042C Partial or full A agonists-N heterocyclic 5' thio substituted adenosine devivatives |
06/02/2004 | CN1152041C C-pyrazoleA receptor agonists |
06/02/2004 | CN1152040C Carbazole derivatives, preparing process thereof and pharmaceutical combination containing the same |
06/02/2004 | CN1151794C Medicinal compositions for treating eye diseases |
06/02/2004 | CN1151775C Method of treating dry eye disease with purinergic receptor agonists |
06/01/2004 | US6743902 For use in antisense therapy for enhancing nuclease resistance and cellular uptake |
06/01/2004 | US6743882 Functionalized silicon compound for use in the treatment of glass |
06/01/2004 | US6743782 Acyl derivative of 2'-deoxyadenosine; treating or preventing radiation, mutagen and sunlight-induced cellular damage, improving wound healing and tissue repair, ameliorating the effects of aging; enhance bioavailability |
05/27/2004 | WO2004043402A2 Modified nucleosides as antiviral agents |
05/27/2004 | US20040102461 Synergistic mixture with anticancer drugs |
05/27/2004 | US20040102414 Methods and compositions for treating flaviviruses and pestiviruses |
05/27/2004 | US20040102413 Method and reagent for the inhibition of telomerase enzyme |
05/27/2004 | US20040101947 A cationic or nonionic surfactant having a hydrophobic-lipophilic balance value from about 11 to 16 and a cell membrane altering compound, used for extracting a protein or peptide from target cell |
05/27/2004 | US20040101932 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
05/27/2004 | US20040101897 Production method for purine nucleotide derivative disodium crystals and alcohol removing method |
05/27/2004 | US20040101892 Nucleic acid labeling compounds |
05/27/2004 | US20040101535 Administering nucleoside, or prodrug thereof; viricides |
05/26/2004 | EP1422225A1 Benzoisoselenazole derivatives with anti-inflammation, antivirus and anti-thrombosis activity and their use |
05/26/2004 | EP1421213A2 Labeled nucleoside polyphosphates |
05/26/2004 | EP1421094A1 4"-deoxy-4"-(s)-amino avermectin derivatives |
05/26/2004 | EP1296996B1 Purine derivatives |
05/26/2004 | CN1500094A Building blocks for solution phase synthesis of oligonucleotides |
05/26/2004 | CN1151167C Purine derivatives |
05/26/2004 | CN1151166C Crystal of diruidine tetraphosphate or salt thereof and method for preparing same, and method for producing said compound |
05/26/2004 | CN1151127C Indole derivatives and their use in the treatment of malignant and other diseases caused by pathological cell proliferation |
05/25/2004 | US6740644 Chemical compounds |
05/21/2004 | WO2004042086A1 Gas jet process and apparatus for high-speed amplification of dna |
05/21/2004 | WO2004042003A2 Cell lysis compositions, methods of use, apparatus, and kit |
05/21/2004 | WO2004041837A1 Novel cytarabine monophosphate prodrugs |
05/21/2004 | WO2004041834A2 Novel cyclic phosphate diesters of 1,3-propane-1-aryl diols and their use in preparing prodrugs |
05/21/2004 | WO2004041828A1 Method of using a porphyrin-like molecule conjugated with an anti-cancer drug for the treatment of cancer |
05/21/2004 | WO2004041203A2 Gemcitabine prodrugs, pharmaceutical compositions and uses thereof |
05/21/2004 | CA2504129A1 Cell lysis compositions, methods of use, apparatus, and kit |
05/20/2004 | US20040097722 Preparation of phosphorothioate oligomers |
05/20/2004 | US20040097462 Methods and compositions for treating flaviviruses and pestiviruses |
05/20/2004 | US20040097461 Methods and compositions for treating hepatitis C Virus |
05/20/2004 | US20040097438 Fused-ring compounds and use thereof as drugs |
05/20/2004 | US20040096947 Biosynthesis using enzyme; immobilized to activated polymer support |
05/20/2004 | US20040096825 Kits for use in multiplexed assay of interaction between ligands/target antiligands |
05/20/2004 | US20040096518 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
05/20/2004 | US20040096397 Sulfonated diarylrhodamine dyes |
05/19/2004 | EP1420021A1 DNA Methyltransferase inhibitors |
05/19/2004 | EP1419778A1 Compositions and methods for the treatment of primary and metastatic neoplastic diseases using arsenic compounds |
05/19/2004 | EP1419167A1 1-(2,5'-anhydro-lyxofuranosyl) thymines for the synthesis of radiomarked fluoro-3 deoxynucleotides |
05/19/2004 | EP1419157A2 HETEROCYCLIC COMPOUND BASED ON N sp 6 /sp −SUBSTITUTED ADENINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE |
05/19/2004 | EP1418949A2 Inhibitor of dna methylation |
05/19/2004 | EP1200478A4 Method for assaying compounds affecting smooth muscle contractile state |
05/19/2004 | DE60101056T2 Verfahren zur Herstellung von Ribavirin Process for the preparation of ribavirin |
05/19/2004 | CN1498221A Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase |
05/19/2004 | CN1496989A New [3,4-a: 3.4-c] carbazole compound, its preparation method and drug composition containing them |
05/18/2004 | US6737236 Derivatizing oligonucleotides and proteins using cycloaddition reactions including diels-alder reaction or 1,3-dipolar cycloaddition reactions |
05/13/2004 | WO2004040003A2 Nucleotide-binding protein-directed probes and methods of their synthesis and use |
05/13/2004 | WO2004039824A1 Modified guanosines having flavouring activity |
05/13/2004 | WO2004039469A2 Process of purifying phosphoramidites |
05/13/2004 | WO2003072586B1 Methods of producing phosphitylated compounds |
05/13/2004 | US20040092476 Anticancer agents; viricides |
05/13/2004 | US20040091407 Novel process for preparing crystalline particles of a salt of a substance, particularly particles of therapeutically useful or carrier substances of a size suitable for inhalation therapy. |
05/13/2004 | CA2502821A1 Process of purifying phosphoramidites |
05/12/2004 | EP1418179A2 Compositions and methods for detecting and modulating rna activity and gene expression |
05/12/2004 | EP1417967A1 Novel virus proliferation inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue |
05/12/2004 | EP1416795A1 Compositions and methods for treatment of mitochondrial diseases |
05/12/2004 | EP0815114B1 Nucleic acid synthesis using photoremovable protecting groups |
05/12/2004 | CN1495186A Method for preparing enkephalinase and angiotensin-converting enzyme inhibitor intermediate and its intermediate |
05/11/2004 | US6734291 Sulfonylation of a di(hydroxymethane)furo(2,3-d)1,3-dioxole derivative with a sulfonyl halide |
05/11/2004 | CA2279428C Compounds and methods for therapeutic intervention in preventing diabetic complications |
05/11/2004 | CA2184411C Process for preparing polymorphs b and c of 1-[2,4-dichloro-.beta.-[(7-chlorobenzo[b]thien-3-yl)methoxy]phenethyl]imidazole mononitrate |
05/06/2004 | WO2004038006A2 Purine nucleosides |
05/06/2004 | WO2004037989A2 Modified nucleotides and methods of labeling nucleic acids |
05/06/2004 | WO2004037842A1 Novel synthetic nucleic acids whose sugar moieties have s-configuration |
05/06/2004 | US20040087555 Phosphohalohydrins, process for the production thereof and use thereof |
05/06/2004 | US20040087541 Crystalline and amorphous forms of beta-L-2'-deoxythymidine |
05/06/2004 | US20040087540 Combinatorial library synthesis and pharmaceutically active compounds produced thereby |
05/06/2004 | US20040087517 Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof |
05/06/2004 | US20040087482 Microparticle-drug conjugates for biological targeting |
05/06/2004 | US20040086914 Binding using ligase |